Bartonella henselae is a gram-negative bacteria that is the causative agent of cat scratch disease (CSD) in humans. CSD is a relatively common infectious disease that primarily affects children and young adults and is usually characterized by regional lymphadenopathy, fever, and sometimes other symptoms like headache or malaise.
The prevalence of B. henselae infection varies widely by geographic region and is generally higher in temperate climates. In the United States, the incidence of CSD is estimated to be around 4.5 cases per 100,000 people per year, with higher rates in certain regions like the southeastern and southwestern states.
Cats are the primary reservoir for B. henselae, and infected cats primarily transmit the infection to humans through scratches or bites. Up to 40% of cats are estimated to carry B. henselae at some point, but most infected cats do not show any signs of illness.
Overall, B. henselae infection is generally considered a mild and self-limiting illness in humans, although severe cases can occur in immunocompromised individuals. There is no specific vaccine or treatment for CSD, but in most cases, symptoms can be managed with supportive care or antibiotics in more severe cases.
It is a small, rod-shaped bacterium that measures about 0.5 to 0.7 microns in width and 1.5 to 3 microns in length.
Bartonella henselae has a cell wall composed of peptidoglycan, lipopolysaccharide, and other proteins. The cell wall protects the bacteria from external stresses and helps it maintain shape.
Bartonella henselae has a single circular chromosome composed of approximately 1.8 million base pairs inside the cell. This chromosome contains all the genetic information necessary for the bacteria to survive and reproduce.
Bartonella henselae also has several plasmids, small, circular pieces of DNA that can replicate independently of the chromosome. These plasmids contain genes that contribute to the bacteria’s virulence and ability to infect host cells.
Bartonella henselae is a gram-negative bacteria that belongs to the family Bartonellaceae, in the order Rhizobiales. It is known to cause cat scratch disease (CSD), a self-limited infection that occurs in humans after a scratch or bite from an infected cat. In addition to CSD, Bartonella henselae has been associated with other diseases, including trench fever and bacillary angiomatosis.
Taxonomically, Bartonella henselae is classified as follows:
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Alphaproteobacteria
Order: Rhizobiales
Family: Bartonellaceae
Genus: Bartonella
Species: Bartonella henselae
There are several subspecies of Bartonella henselae, including:
Bartonella henselae subsp. henselae
Bartonella henselae subsp. vinsonii
Bartonella henselae subsp. Birtlesii
These subspecies have different geographic distributions and can cause different clinical manifestations.
It is also responsible for other human diseases, including trench fever and bacillary angiomatosis. There are two antigenic types of B. henselae, designated type I and type II, based on differences in their surface antigens.
Type I strains of B. henselae are the most common and are found worldwide. They are associated with cat scratch disease and bacillary angiomatosis, a vascular tumor-like lesion mainly in immunocompromised individuals. Type I strains have been isolated from cats and humans and are thought to be the primary cause of B. henselae infections in both species.
Type II strains of B. henselae are less common and are mainly found in Europe. They are associated with a more severe form of cat scratch disease and endocarditis, an infection of the heart valves. Type II strains have been isolated mainly from humans but have also been found in cats.
The pathogenesis of Bartonella henselae involves several steps:
Entry into the host: Bartonella henselae gains entry into the host through a break in the skin caused by the scratch or bite of an infected cat or through the bites of infected fleas.
Adhesion and invasion: Once inside the host, Bartonella henselae adheres to endothelial cells lining the blood vessels and invades them. This process is facilitated by several bacterial adhesins, including the VirB/VirD4 type IV secretion system, Trw system, and BadA protein.
Induction of angiogenesis: Bartonella henselae induces the formation of new blood vessels, a process known as angiogenesis, to provide nutrients and evade the host immune system. It is achieved through the secretion of angiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8).
Immune evasion: Bartonella henselae can evade the host immune system through several mechanisms, including the inhibition of complement-mediated lysis, downregulation of major histocompatibility complex (MHC) expression, and the production of immunosuppressive factors such as Bartonella adhesin A (BadA).
Systemic dissemination: In immunocompromised individuals, Bartonella henselae can disseminate systemically, developing bacillary angiomatosis or trench fever.
To defend against this bacterium, the human body has several host defense mechanisms:
Immune response: When the body detects the presence of Bartonella henselae, the immune system responds by producing antibodies that target and destroy the bacterium. In addition, specific immune cells, such as macrophages and neutrophils, are recruited to the site of infection to engulf and eliminate the bacteria.
Inflammation: Inflammation is a natural response to infection, and it helps to isolate and contain the invading pathogen. In the case of Bartonella henselae, inflammation can cause redness, swelling, and pain at the site of infection.
Fever: Fever is another typical response to infection, and it helps to activate the immune system and inhibit the growth of bacteria. In the case of Bartonella henselae, fever may occur as the body tries to fight off the infection.
Physical barriers: The skin is the first line of defense against bacterial infections, and intact skin can prevent Bartonella henselae from entering the body. However, if the skin is broken, for example, by a cat scratch, the bacterium can enter the body and cause infection.
Antibiotics: In severe cases, antibiotics may be necessary to treat infections caused by Bartonella henselae. These drugs can help to kill the bacteria and prevent the infection from spreading.
The following are the host defenses that are involved in the immune response against Bartonella henselae:
Innate Immunity: The innate immune system is the first defense against invading pathogens. It includes physical barriers such as skin and mucous membranes and cells such as neutrophils, macrophages, and natural killer cells. These cells can recognize and eliminate Bartonella henselae through phagocytosis, cytokine secretion, and other mechanisms.
Adaptive Immunity: The adaptive immune system provides a specific response to Bartonella henselae after exposure. B cells produce antibodies that recognize and bind to the bacterium, while T cells can recognize and kill infected cells. The adaptive immune response is critical for long-term protection against Bartonella henselae.
Complement System: The complement system is a set of proteins that can activate a cascade of reactions to destroy pathogens. The complement system can recognize and bind to Bartonella henselae, leading to its destruction through cell lysis and phagocytosis.
Inflammatory Response: The inflammatory response is a complex process that involves the release of cytokines, chemokines, and other signaling molecules. These molecules attract immune cells to the site of infection and activate them to eliminate Bartonella henselae. However, excessive inflammation can also lead to tissue damage.
Fever: Fever is a response to infection that can help to limit the growth of bacteria such as Bartonella henselae. Elevated body temperature can also enhance immune cell function.
Diagnosis of Bartonella henselae infection is typically made based on clinical symptoms and laboratory tests.
Clinical symptoms may include a blister or abscess at a cat scratch or bite site, fever, headache, fatigue, and swollen lymph nodes. However, other factors can also contribute to these symptoms. Infections or medical conditions, so laboratory tests are necessary to confirm the diagnosis.
Some laboratory tests that can be used to diagnose Bartonella henselae infection include:
Serology tests: These tests look for antibodies to Bartonella henselae in the blood. They can indicate whether a person has been exposed to the bacteria in the past, but they may only be positive several weeks after the infection.
Polymerase chain reaction (PCR) tests: These tests look for genetic material from Bartonella henselae in blood or tissue samples. PCR tests are susceptible and can detect the bacteria early in the infection.
Culture: Bartonella henselae can be cultured from blood or tissue samples, but this method is time-consuming and not commonly used.
Control measures for Bartonella henselae:
Preventing contact with infected cats: Infected cats shed the bacteria in their saliva, so avoiding getting scratched or bitten is essential. Avoid petting or playing with feral or stray cats, and wash your hands after handling cats.
Treating infected cats: Infected cats can be treated with antibiotics to eliminate the bacteria. If you suspect your cat has cat-scratch disease, immediately take it to a veterinarian.
Avoiding fleas: Fleas are the primary vector for Bartonella henselae, so taking measures to control flea infestations is essential. Use flea treatments on pets and keep the environment clean and free of debris that could harbor fleas.
Good hygiene practices: Wash your hands frequently, especially after handling cats or other animals, and avoid rubbing your eyes or mouth after contact with animals.
Treating infections in humans: Most cases of cat-scratch disease resolve independently, but if the infection is severe or complications develop, antibiotics may be necessary. If you develop symptoms of cat-scratch disease, such as a fever, swollen lymph nodes, or a rash, seek medical attention.
Bartonella henselae is a gram-negative bacteria that is the causative agent of cat scratch disease (CSD) in humans. CSD is a relatively common infectious disease that primarily affects children and young adults and is usually characterized by regional lymphadenopathy, fever, and sometimes other symptoms like headache or malaise.
The prevalence of B. henselae infection varies widely by geographic region and is generally higher in temperate climates. In the United States, the incidence of CSD is estimated to be around 4.5 cases per 100,000 people per year, with higher rates in certain regions like the southeastern and southwestern states.
Cats are the primary reservoir for B. henselae, and infected cats primarily transmit the infection to humans through scratches or bites. Up to 40% of cats are estimated to carry B. henselae at some point, but most infected cats do not show any signs of illness.
Overall, B. henselae infection is generally considered a mild and self-limiting illness in humans, although severe cases can occur in immunocompromised individuals. There is no specific vaccine or treatment for CSD, but in most cases, symptoms can be managed with supportive care or antibiotics in more severe cases.
It is a small, rod-shaped bacterium that measures about 0.5 to 0.7 microns in width and 1.5 to 3 microns in length.
Bartonella henselae has a cell wall composed of peptidoglycan, lipopolysaccharide, and other proteins. The cell wall protects the bacteria from external stresses and helps it maintain shape.
Bartonella henselae has a single circular chromosome composed of approximately 1.8 million base pairs inside the cell. This chromosome contains all the genetic information necessary for the bacteria to survive and reproduce.
Bartonella henselae also has several plasmids, small, circular pieces of DNA that can replicate independently of the chromosome. These plasmids contain genes that contribute to the bacteria’s virulence and ability to infect host cells.
Bartonella henselae is a gram-negative bacteria that belongs to the family Bartonellaceae, in the order Rhizobiales. It is known to cause cat scratch disease (CSD), a self-limited infection that occurs in humans after a scratch or bite from an infected cat. In addition to CSD, Bartonella henselae has been associated with other diseases, including trench fever and bacillary angiomatosis.
Taxonomically, Bartonella henselae is classified as follows:
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Alphaproteobacteria
Order: Rhizobiales
Family: Bartonellaceae
Genus: Bartonella
Species: Bartonella henselae
There are several subspecies of Bartonella henselae, including:
Bartonella henselae subsp. henselae
Bartonella henselae subsp. vinsonii
Bartonella henselae subsp. Birtlesii
These subspecies have different geographic distributions and can cause different clinical manifestations.
It is also responsible for other human diseases, including trench fever and bacillary angiomatosis. There are two antigenic types of B. henselae, designated type I and type II, based on differences in their surface antigens.
Type I strains of B. henselae are the most common and are found worldwide. They are associated with cat scratch disease and bacillary angiomatosis, a vascular tumor-like lesion mainly in immunocompromised individuals. Type I strains have been isolated from cats and humans and are thought to be the primary cause of B. henselae infections in both species.
Type II strains of B. henselae are less common and are mainly found in Europe. They are associated with a more severe form of cat scratch disease and endocarditis, an infection of the heart valves. Type II strains have been isolated mainly from humans but have also been found in cats.
The pathogenesis of Bartonella henselae involves several steps:
Entry into the host: Bartonella henselae gains entry into the host through a break in the skin caused by the scratch or bite of an infected cat or through the bites of infected fleas.
Adhesion and invasion: Once inside the host, Bartonella henselae adheres to endothelial cells lining the blood vessels and invades them. This process is facilitated by several bacterial adhesins, including the VirB/VirD4 type IV secretion system, Trw system, and BadA protein.
Induction of angiogenesis: Bartonella henselae induces the formation of new blood vessels, a process known as angiogenesis, to provide nutrients and evade the host immune system. It is achieved through the secretion of angiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8).
Immune evasion: Bartonella henselae can evade the host immune system through several mechanisms, including the inhibition of complement-mediated lysis, downregulation of major histocompatibility complex (MHC) expression, and the production of immunosuppressive factors such as Bartonella adhesin A (BadA).
Systemic dissemination: In immunocompromised individuals, Bartonella henselae can disseminate systemically, developing bacillary angiomatosis or trench fever.
To defend against this bacterium, the human body has several host defense mechanisms:
Immune response: When the body detects the presence of Bartonella henselae, the immune system responds by producing antibodies that target and destroy the bacterium. In addition, specific immune cells, such as macrophages and neutrophils, are recruited to the site of infection to engulf and eliminate the bacteria.
Inflammation: Inflammation is a natural response to infection, and it helps to isolate and contain the invading pathogen. In the case of Bartonella henselae, inflammation can cause redness, swelling, and pain at the site of infection.
Fever: Fever is another typical response to infection, and it helps to activate the immune system and inhibit the growth of bacteria. In the case of Bartonella henselae, fever may occur as the body tries to fight off the infection.
Physical barriers: The skin is the first line of defense against bacterial infections, and intact skin can prevent Bartonella henselae from entering the body. However, if the skin is broken, for example, by a cat scratch, the bacterium can enter the body and cause infection.
Antibiotics: In severe cases, antibiotics may be necessary to treat infections caused by Bartonella henselae. These drugs can help to kill the bacteria and prevent the infection from spreading.
The following are the host defenses that are involved in the immune response against Bartonella henselae:
Innate Immunity: The innate immune system is the first defense against invading pathogens. It includes physical barriers such as skin and mucous membranes and cells such as neutrophils, macrophages, and natural killer cells. These cells can recognize and eliminate Bartonella henselae through phagocytosis, cytokine secretion, and other mechanisms.
Adaptive Immunity: The adaptive immune system provides a specific response to Bartonella henselae after exposure. B cells produce antibodies that recognize and bind to the bacterium, while T cells can recognize and kill infected cells. The adaptive immune response is critical for long-term protection against Bartonella henselae.
Complement System: The complement system is a set of proteins that can activate a cascade of reactions to destroy pathogens. The complement system can recognize and bind to Bartonella henselae, leading to its destruction through cell lysis and phagocytosis.
Inflammatory Response: The inflammatory response is a complex process that involves the release of cytokines, chemokines, and other signaling molecules. These molecules attract immune cells to the site of infection and activate them to eliminate Bartonella henselae. However, excessive inflammation can also lead to tissue damage.
Fever: Fever is a response to infection that can help to limit the growth of bacteria such as Bartonella henselae. Elevated body temperature can also enhance immune cell function.
Diagnosis of Bartonella henselae infection is typically made based on clinical symptoms and laboratory tests.
Clinical symptoms may include a blister or abscess at a cat scratch or bite site, fever, headache, fatigue, and swollen lymph nodes. However, other factors can also contribute to these symptoms. Infections or medical conditions, so laboratory tests are necessary to confirm the diagnosis.
Some laboratory tests that can be used to diagnose Bartonella henselae infection include:
Serology tests: These tests look for antibodies to Bartonella henselae in the blood. They can indicate whether a person has been exposed to the bacteria in the past, but they may only be positive several weeks after the infection.
Polymerase chain reaction (PCR) tests: These tests look for genetic material from Bartonella henselae in blood or tissue samples. PCR tests are susceptible and can detect the bacteria early in the infection.
Culture: Bartonella henselae can be cultured from blood or tissue samples, but this method is time-consuming and not commonly used.
Control measures for Bartonella henselae:
Preventing contact with infected cats: Infected cats shed the bacteria in their saliva, so avoiding getting scratched or bitten is essential. Avoid petting or playing with feral or stray cats, and wash your hands after handling cats.
Treating infected cats: Infected cats can be treated with antibiotics to eliminate the bacteria. If you suspect your cat has cat-scratch disease, immediately take it to a veterinarian.
Avoiding fleas: Fleas are the primary vector for Bartonella henselae, so taking measures to control flea infestations is essential. Use flea treatments on pets and keep the environment clean and free of debris that could harbor fleas.
Good hygiene practices: Wash your hands frequently, especially after handling cats or other animals, and avoid rubbing your eyes or mouth after contact with animals.
Treating infections in humans: Most cases of cat-scratch disease resolve independently, but if the infection is severe or complications develop, antibiotics may be necessary. If you develop symptoms of cat-scratch disease, such as a fever, swollen lymph nodes, or a rash, seek medical attention.
Bartonella henselae is a gram-negative bacteria that is the causative agent of cat scratch disease (CSD) in humans. CSD is a relatively common infectious disease that primarily affects children and young adults and is usually characterized by regional lymphadenopathy, fever, and sometimes other symptoms like headache or malaise.
The prevalence of B. henselae infection varies widely by geographic region and is generally higher in temperate climates. In the United States, the incidence of CSD is estimated to be around 4.5 cases per 100,000 people per year, with higher rates in certain regions like the southeastern and southwestern states.
Cats are the primary reservoir for B. henselae, and infected cats primarily transmit the infection to humans through scratches or bites. Up to 40% of cats are estimated to carry B. henselae at some point, but most infected cats do not show any signs of illness.
Overall, B. henselae infection is generally considered a mild and self-limiting illness in humans, although severe cases can occur in immunocompromised individuals. There is no specific vaccine or treatment for CSD, but in most cases, symptoms can be managed with supportive care or antibiotics in more severe cases.
Structure and Classification
It is a small, rod-shaped bacterium that measures about 0.5 to 0.7 microns in width and 1.5 to 3 microns in length.
Bartonella henselae has a cell wall composed of peptidoglycan, lipopolysaccharide, and other proteins. The cell wall protects the bacteria from external stresses and helps it maintain shape.
Bartonella henselae has a single circular chromosome composed of approximately 1.8 million base pairs inside the cell. This chromosome contains all the genetic information necessary for the bacteria to survive and reproduce.
Bartonella henselae also has several plasmids, small, circular pieces of DNA that can replicate independently of the chromosome. These plasmids contain genes that contribute to the bacteria’s virulence and ability to infect host cells.
Bartonella henselae is a gram-negative bacteria that belongs to the family Bartonellaceae, in the order Rhizobiales. It is known to cause cat scratch disease (CSD), a self-limited infection that occurs in humans after a scratch or bite from an infected cat. In addition to CSD, Bartonella henselae has been associated with other diseases, including trench fever and bacillary angiomatosis.
Taxonomically, Bartonella henselae is classified as follows:
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Alphaproteobacteria
Order: Rhizobiales
Family: Bartonellaceae
Genus: Bartonella
Species: Bartonella henselae
There are several subspecies of Bartonella henselae, including:
Bartonella henselae subsp. henselae
Bartonella henselae subsp. vinsonii
Bartonella henselae subsp. Birtlesii
These subspecies have different geographic distributions and can cause different clinical manifestations.
Antigenic Types
It is also responsible for other human diseases, including trench fever and bacillary angiomatosis. There are two antigenic types of B. henselae, designated type I and type II, based on differences in their surface antigens.
Type I strains of B. henselae are the most common and are found worldwide. They are associated with cat scratch disease and bacillary angiomatosis, a vascular tumor-like lesion mainly in immunocompromised individuals. Type I strains have been isolated from cats and humans and are thought to be the primary cause of B. henselae infections in both species.
Type II strains of B. henselae are less common and are mainly found in Europe. They are associated with a more severe form of cat scratch disease and endocarditis, an infection of the heart valves. Type II strains have been isolated mainly from humans but have also been found in cats.
Pathogenesis
The pathogenesis of Bartonella henselae involves several steps:
Entry into the host: Bartonella henselae gains entry into the host through a break in the skin caused by the scratch or bite of an infected cat or through the bites of infected fleas.
Adhesion and invasion: Once inside the host, Bartonella henselae adheres to endothelial cells lining the blood vessels and invades them. This process is facilitated by several bacterial adhesins, including the VirB/VirD4 type IV secretion system, Trw system, and BadA protein.
Induction of angiogenesis: Bartonella henselae induces the formation of new blood vessels, a process known as angiogenesis, to provide nutrients and evade the host immune system. It is achieved through the secretion of angiogenic factors, such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8).
Immune evasion: Bartonella henselae can evade the host immune system through several mechanisms, including the inhibition of complement-mediated lysis, downregulation of major histocompatibility complex (MHC) expression, and the production of immunosuppressive factors such as Bartonella adhesin A (BadA).
Systemic dissemination: In immunocompromised individuals, Bartonella henselae can disseminate systemically, developing bacillary angiomatosis or trench fever.
Host Defences
To defend against this bacterium, the human body has several host defense mechanisms:
Immune response: When the body detects the presence of Bartonella henselae, the immune system responds by producing antibodies that target and destroy the bacterium. In addition, specific immune cells, such as macrophages and neutrophils, are recruited to the site of infection to engulf and eliminate the bacteria.
Inflammation: Inflammation is a natural response to infection, and it helps to isolate and contain the invading pathogen. In the case of Bartonella henselae, inflammation can cause redness, swelling, and pain at the site of infection.
Fever: Fever is another typical response to infection, and it helps to activate the immune system and inhibit the growth of bacteria. In the case of Bartonella henselae, fever may occur as the body tries to fight off the infection.
Physical barriers: The skin is the first line of defense against bacterial infections, and intact skin can prevent Bartonella henselae from entering the body. However, if the skin is broken, for example, by a cat scratch, the bacterium can enter the body and cause infection.
Antibiotics: In severe cases, antibiotics may be necessary to treat infections caused by Bartonella henselae. These drugs can help to kill the bacteria and prevent the infection from spreading.
Clinical manifestations
The following are the host defenses that are involved in the immune response against Bartonella henselae:
Innate Immunity: The innate immune system is the first defense against invading pathogens. It includes physical barriers such as skin and mucous membranes and cells such as neutrophils, macrophages, and natural killer cells. These cells can recognize and eliminate Bartonella henselae through phagocytosis, cytokine secretion, and other mechanisms.
Adaptive Immunity: The adaptive immune system provides a specific response to Bartonella henselae after exposure. B cells produce antibodies that recognize and bind to the bacterium, while T cells can recognize and kill infected cells. The adaptive immune response is critical for long-term protection against Bartonella henselae.
Complement System: The complement system is a set of proteins that can activate a cascade of reactions to destroy pathogens. The complement system can recognize and bind to Bartonella henselae, leading to its destruction through cell lysis and phagocytosis.
Inflammatory Response: The inflammatory response is a complex process that involves the release of cytokines, chemokines, and other signaling molecules. These molecules attract immune cells to the site of infection and activate them to eliminate Bartonella henselae. However, excessive inflammation can also lead to tissue damage.
Fever: Fever is a response to infection that can help to limit the growth of bacteria such as Bartonella henselae. Elevated body temperature can also enhance immune cell function.
Diagnosis
Diagnosis of Bartonella henselae infection is typically made based on clinical symptoms and laboratory tests.
Clinical symptoms may include a blister or abscess at a cat scratch or bite site, fever, headache, fatigue, and swollen lymph nodes. However, other factors can also contribute to these symptoms. Infections or medical conditions, so laboratory tests are necessary to confirm the diagnosis.
Some laboratory tests that can be used to diagnose Bartonella henselae infection include:
Serology tests: These tests look for antibodies to Bartonella henselae in the blood. They can indicate whether a person has been exposed to the bacteria in the past, but they may only be positive several weeks after the infection.
Polymerase chain reaction (PCR) tests: These tests look for genetic material from Bartonella henselae in blood or tissue samples. PCR tests are susceptible and can detect the bacteria early in the infection.
Culture: Bartonella henselae can be cultured from blood or tissue samples, but this method is time-consuming and not commonly used.
Control
Control measures for Bartonella henselae:
Preventing contact with infected cats: Infected cats shed the bacteria in their saliva, so avoiding getting scratched or bitten is essential. Avoid petting or playing with feral or stray cats, and wash your hands after handling cats.
Treating infected cats: Infected cats can be treated with antibiotics to eliminate the bacteria. If you suspect your cat has cat-scratch disease, immediately take it to a veterinarian.
Avoiding fleas: Fleas are the primary vector for Bartonella henselae, so taking measures to control flea infestations is essential. Use flea treatments on pets and keep the environment clean and free of debris that could harbor fleas.
Good hygiene practices: Wash your hands frequently, especially after handling cats or other animals, and avoid rubbing your eyes or mouth after contact with animals.
Treating infections in humans: Most cases of cat-scratch disease resolve independently, but if the infection is severe or complications develop, antibiotics may be necessary. If you develop symptoms of cat-scratch disease, such as a fever, swollen lymph nodes, or a rash, seek medical attention.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
